Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: An observational study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Kumar, Sanjeev ^a   Chapagain, Ananda ^a   Nitsch, Dorothea ^b   Yaqoob, Muhammad M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Hypoalbuminemia; Membranous nephropathy; Proteinuria; Thromboembolism

Indexed keywords

ALBUMIN; AZATHIOPRINE; CHOLESTEROL; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; WARFARIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; OBSERVATIONAL STUDY; PROTEINURIA; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM;

ADULT; AGED; COMORBIDITY; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GREAT BRITAIN; HUMANS; HYPOALBUMINEMIA; INCIDENCE; MALE; MIDDLE AGED; PROTEINURIA; RISK FACTORS; THROMBOEMBOLISM;

EID: 84865836700     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-107     Document Type: Article

References (26)

1. Management of membranous nephropathy: when and what for treatment. Cattran D, J Am Soc Nephrol 2005 16 1188 1194 10.1681/ASN.2005010028 15800117
2. The nephrotic syndrome. Orth SR, Ritz E, N Engl J Med 1998 338 1202 1211 10.1056/NEJM199804233381707 9554862
3. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Singhal R, Brimble KS, Thromb Res 2006 118 397 407 10.1016/j.thromres.2005.03.030 15990160
4. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J, Circulation 2008 117 224 230 10.1161/CIRCULATIONAHA. 107.716951 18158362
5. The clinical spectrum of renal vein thrombosis: acute and chronic. Llach F, Papper S, Massry SG, Am J Med 1980 69 819 827 10.1016/S0002-9343(80)80006-4 7446547
6. Renal vein thrombosis in nephrotic syndrome-a prospective study and review. Chugh KS, Malik N, Uberoi HS, Gupta VK, Aggarwal ML, Singhal PC, Suri S, Jain SK, Postgrad Med J 1981 57 566 570 10.1136/pgmj.57.671.566 7329894
7. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Wagoner RD, Stanson AW, Holley KE, Winter CS, Kidney Int 1983 23 368 374 10.1038/ki.1983.28 6842962
8. Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Velasquez Forero F, Garcia Prugue N, Ruiz Morales N, Am J Nephrol 1988 8 457 462 10.1159/000167654 3218659
9. Idiopathic membranous nephropathy in an Australian population: the incidence of thromboembolism and its impact on the natural history. Bellomo R, Wood C, Wagner I, Agar J, Dowling J, Thomson N, Atkins R, Nephron 1993 63 240 241 8450923
10. Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. Glassock RJ, J Am Soc Nephrol 2007 18 2221 2225 10.1681/ASN.2006111300 17599972
11. Hopkins Lupus Cohort. 1999 update. Petri M, Rheum Dis Clin North Am 2000 26 199 213 v 10.1016/S0889-857X(05)70135-6 10768209
12. Human immunodeficiency virus infection and risk of venous thromboembolism. Matta F, Yaekoub AY, Stein PD, Am J Med Sci 2008 336 402 406 10.1097/MAJ.0b013e31816dd2fd 19011397
13. Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants. Lee AY, Hematology Am Soc Hematol Educ Program 2010 2010 144 149 10.1182/asheducation-2010.1.144 21239784
14. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Kauffmann RH, Veltkamp JJ, Van Tilburg NH, Van Es LA, Am J Med 1978 65 607 613 10.1016/0002-9343(78)90848-3 707521
15. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Vaziri ND, Paule P, Toohey J, Hung E, Alikhani S, Darwish R, Pahl MV, Arch Intern Med 1984 144 1802 1803 10.1001/archinte.1984. 00350210124021 6477000
16. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome. Boneu B, Bouissou F, Abbal M, Sie P, Caranobe C, Barthe P, Thromb Haemost 1981 46 623 625 6171906
17. Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes. de Sain-van Velde MG, Kaysen GA, de Meer K, Stellaard F, Voorbij HA, Reijngoud DJ, Rabelink TJ, Koomans HA, Kidney Int 1998 53 181 188 10.1046/j.1523-1755.1998.00729.x 9453016
18. Protein S deficiency occurs in the nephrotic syndrome. Vigano-DAngelo S, DAngelo A, Kaufman CE Jr, Sholer C, Esmon CT, Comp PC, Ann Intern Med 1987 107 42 47 2954500
19. Definition, incidence, and clinical description of flare in systemic lupus erythematosus a prospective cohort study. Petri M, Genovese M, Engle E, Hochberg M, Arthritis Rheum 1991 34 937 944 10.1002/art.1780340802 1859487
20. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC Jr, Hoffman GS, McCune WJ, St Clair EW, Specks U, Ann Intern Med 2005 142 620 626 15838068
21. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, et al. N Engl J Med 2003 348 1425 1434 10.1056/NEJMoa035029 12601075
22. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Kayali F, Najjar R, Aswad F, Matta F, Stein PD, Am J Med 2008 121 226 230 10.1016/j.amjmed.2007.08.042 18328307
23. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE, J Pediatr 2009 155 105 110 110 e101 10.1016/j.jpeds.2009.01.070 19394032
24. Relationship between proteinuria and venous thromboembolism. Kato S, Chernyavsky S, Tokita JE, Shimada YJ, Homel P, Rosen H, Winchester JF, J Thromb Thrombolysis 2010 30 281 285 10.1007/s11239-010-0442-z 20157844
25. Microalbuminuria and risk of venous thromboembolism. Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, Hillege HL, van der Meer J, JAMA 2009 301 1790 1797 10.1001/jama.2009.565 19417196
26. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, Singer DE, Circulation 2009 119 1363 1369 10.1161/CIRCULATIONAHA.108.816082 19255343